Li Chen

[Li Chen @Li_Chen363]

Synthetic transcription factors designed by domain recombination enhance CAR T cell antitumor function: Cell https://t.co/9XBBDgpGQF
Interesting work！

[Li Chen @Li_Chen363]

@Rotem_Shalita Really perfect work! Congratulations, Rotem!

[Li Chen @Li_Chen363]

Congratulations to the team on this exciting work! 🎉 A fascinating approach to engineering safer and more effective CAR T cells for MS by targeting pathogenic PD-1⁺ T cells and reprogramming neuroinflammation. Truly inspiring work by the team!

[IdoAmitLab @IdoAmitLab]

1/15 Can we engineer safer, more effective CAR T cells for MS? New in @CellCellPress: we identify pathogenic PD-1⁺ T cells and target them with inflammation-gated CAR T cells that reprogram neuroinflammation. @Rotem_Shalita @mayaby15 Chamutal Gur
https://t.co/hhzGC7VibI

[IdoAmitLab @IdoAmitLab]

1/15 Can we engineer safer, more effective CAR T cells for MS? New in @CellCellPress: we identify pathogenic PD-1⁺ T cells and target them with inflammation-gated CAR T cells that reprogram neuroinflammation. @Rotem_Shalita @mayaby15 Chamutal Gur
https://t.co/hhzGC7VibI

[Li Chen @Li_Chen363]

Excited to introduce our drug-inducible system PRINCE to the community — a new step forward in controlling CRISPR with improved genomic precision.
Hope to see CRISPR tools go even further!
Huge thanks to my supervisor and all friends!
https://t.co/Dg0IWnQ1tB